From Non-Invasive Hemodynamic Measurements towards Patient-Specific Cardiovascular Diagnosis

Author(s):  
Stefan Bernhard ◽  
Kristine Al Zoukra ◽  
Christof Schtte

The past two decades have seen impressive success in medical technology, generating novel experimental data at an unexpected rate. However, current computational methods cannot sufficiently manage the data analysis for interpretation, so clinical application is hindered, and the benefit for the patient is still small. Even though numerous physiological models have been developed to describe complex dynamical mechanisms, their clinical application is limited, because parameterization is crucial, and most problems are ill-posed and do not have unique solutions. However, this information deficit is imminent to physiological data, because the measurement process always contains contamination like artifacts or noise and is limited by a finite measurement precision. The lack of information in hemodynamic data measured at the outlet of the left ventricle, for example, induces an infinite number of solutions to the hemodynamic inverse problem (possible vascular morphologies that can represent the hemodynamic conditions) (Quick, 2001). Within this work, we propose that, despite these problems, the assimilation of morphological constraints, and the usage of statistical prior knowledge from clinical observations, reveals diagnostically useful information. If the morphology of the vascular network, for example, is constrained by a set of time series measurements taken at specific places of the cardiovascular system, it is possible to solve the hemodynamic inverse problem by a carefully designed mathematical forward model in combination with a Bayesian inference technique. The proposed cardiovascular system identification procedure allows us to deduce patient-specific information that can be used to diagnose a variety of cardiovascular diseases in an early state. In contrast to traditional inversion approaches, the novel method produces a distribution of physiologically interpretable models (patient-specific parameters and model states) that allow the identification of disease specific patterns that correspond to clinical diagnoses, enabling a probabilistic assessment of human health condition on the basis of a broad patient population. In the ongoing work we use this technique to identify arterial stenosis and aneurisms from anomalous patterns in signal and parameter space. The novel data mining procedure provides useful clinical information about the location of vascular defects like aneurisms and stenosis. We conclude that the Bayesian inference approach is able to solve the cardiovascular inverse problem and to interpret clinical data to allow a patient-specific model-based diagnosis of cardiovascular diseases. We think that the information-based approach provides a useful link between mathematical physiology and clinical diagnoses and that it will become constituent in the medical decision process in near future.

Data Mining ◽  
2013 ◽  
pp. 2069-2093
Author(s):  
Stefan Bernhard ◽  
Kristine Al Zoukra ◽  
Christof Schtte

The past two decades have seen impressive success in medical technology, generating novel experimental data at an unexpected rate. However, current computational methods cannot sufficiently manage the data analysis for interpretation, so clinical application is hindered, and the benefit for the patient is still small. Even though numerous physiological models have been developed to describe complex dynamical mechanisms, their clinical application is limited, because parameterization is crucial, and most problems are ill-posed and do not have unique solutions. However, this information deficit is imminent to physiological data, because the measurement process always contains contamination like artifacts or noise and is limited by a finite measurement precision. The lack of information in hemodynamic data measured at the outlet of the left ventricle, for example, induces an infinite number of solutions to the hemodynamic inverse problem (possible vascular morphologies that can represent the hemodynamic conditions) (Quick, 2001). Within this work, we propose that, despite these problems, the assimilation of morphological constraints, and the usage of statistical prior knowledge from clinical observations, reveals diagnostically useful information. If the morphology of the vascular network, for example, is constrained by a set of time series measurements taken at specific places of the cardiovascular system, it is possible to solve the hemodynamic inverse problem by a carefully designed mathematical forward model in combination with a Bayesian inference technique. The proposed cardiovascular system identification procedure allows us to deduce patient-specific information that can be used to diagnose a variety of cardiovascular diseases in an early state. In contrast to traditional inversion approaches, the novel method produces a distribution of physiologically interpretable models (patient-specific parameters and model states) that allow the identification of disease specific patterns that correspond to clinical diagnoses, enabling a probabilistic assessment of human health condition on the basis of a broad patient population. In the ongoing work we use this technique to identify arterial stenosis and aneurisms from anomalous patterns in signal and parameter space. The novel data mining procedure provides useful clinical information about the location of vascular defects like aneurisms and stenosis. We conclude that the Bayesian inference approach is able to solve the cardiovascular inverse problem and to interpret clinical data to allow a patient-specific model-based diagnosis of cardiovascular diseases. We think that the information-based approach provides a useful link between mathematical physiology and clinical diagnoses and that it will become constituent in the medical decision process in near future.


2020 ◽  
Vol 134 (17) ◽  
pp. 2243-2262
Author(s):  
Danlin Liu ◽  
Gavin Richardson ◽  
Fehmi M. Benli ◽  
Catherine Park ◽  
João V. de Souza ◽  
...  

Abstract In the elderly population, pathological inflammation has been associated with ageing-associated diseases. The term ‘inflammageing’, which was used for the first time by Franceschi and co-workers in 2000, is associated with the chronic, low-grade, subclinical inflammatory processes coupled to biological ageing. The source of these inflammatory processes is debated. The senescence-associated secretory phenotype (SASP) has been proposed as the main origin of inflammageing. The SASP is characterised by the release of inflammatory cytokines, elevated activation of the NLRP3 inflammasome, altered regulation of acetylcholine (ACh) nicotinic receptors, and abnormal NAD+ metabolism. Therefore, SASP may be ‘druggable’ by small molecule therapeutics targeting those emerging molecular targets. It has been shown that inflammageing is a hallmark of various cardiovascular diseases, including atherosclerosis, hypertension, and adverse cardiac remodelling. Therefore, the pathomechanism involving SASP activation via the NLRP3 inflammasome; modulation of NLRP3 via α7 nicotinic ACh receptors; and modulation by senolytics targeting other proteins have gained a lot of interest within cardiovascular research and drug development communities. In this review, which offers a unique view from both clinical and preclinical target-based drug discovery perspectives, we have focused on cardiovascular inflammageing and its molecular mechanisms. We have outlined the mechanistic links between inflammageing, SASP, interleukin (IL)-1β, NLRP3 inflammasome, nicotinic ACh receptors, and molecular targets of senolytic drugs in the context of cardiovascular diseases. We have addressed the ‘druggability’ of NLRP3 and nicotinic α7 receptors by small molecules, as these proteins represent novel and exciting targets for therapeutic interventions targeting inflammageing in the cardiovascular system and beyond.


2011 ◽  
pp. 5-12
Author(s):  
Anh Tien Hoang ◽  
Van Minh Huynh ◽  
Khanh Hoang ◽  
Huu Dang Tran ◽  
Viet An Tran

NT-ProBNP is a high value cardiac biomarker and widely applies in many cardiovascular diseases. The evaluation of concentration of NT-ProBNP needs the concern about age, gender, obesity and especially we need each cut-off point for each cause of cardiovascular disease in evaluation and clinical application. Because NT-ProBNP is a new cardiac marker and has been researched in 5 recent years, the cut-off of NT-ProBNP is still being studied for the clinical application in cardiovascular diseases. Only the cut-off of NT-ProBNP in diagnosis heart failure was guided by European Society of Cardiology. The meaning of introduce cut-off value of value plays an role as pilot study for the other relate study and brings the NT-ProBNP closely approach to clinical application.


2018 ◽  
Vol 24 (24) ◽  
pp. 2876-2882 ◽  
Author(s):  
Kailash Prasad

Cardiovascular diseases (CVD) may be mediated through increases in the cardiovascular risk factors. Hemoglobin A1c (HbA1c) also called glycated hemoglobin is presently used for the diagnosis and management of diabetes. It has adverse effects on cardiovascular system. This review deals with its synthesis and effects on the cardiovascular system. The serum levels of HbA1c have been reported to be affected by various factors including, the lifespan of erythrocytes, factors affecting erythropoiesis, agents interfering glycation of Hb, destruction of erythrocytes, drugs that shift the formation of Hb, statins, and drugs interfering the HbA1c assay. Levels of HbA1c are positively correlated with serum glucose and advanced glycation end products ( AGE), but no correlation between AGE and serum glucose. AGE cannot replace HbA1c for the diagnosis and management of diabetes because there is no correlation of AGE with serum glucose, and because the half-life of protein with which glucose combines is only 14-20 days as compared to erythrocytes which have a half-life of 90-120 days. HbA1c is positively associated with CVD such as the carotid and coronary artery atherosclerosis, ischemic heart disease, ischemic stroke and hypertension.HbA1c induces dyslipidemia, hyperhomocysteinemia, and hypertension, and increases C-reactive protein, oxidative stress and blood viscosity that would contribute to the development of cardiovascular diseases. In conclusion, HbA1c serves as a useful marker for the diagnosis and management of diabetes. AGE cannot replace HbA1c in the diagnosis and management of diabetes. There is an association of HbA1c with CVD which be mediated through modulation of CVD risk factors.


2020 ◽  
Vol 15 (3) ◽  
pp. 187-201 ◽  
Author(s):  
Sunil K. Dubey ◽  
Amit Alexander ◽  
Munnangi Sivaram ◽  
Mukta Agrawal ◽  
Gautam Singhvi ◽  
...  

Damaged or disabled tissue is life-threatening due to the lack of proper treatment. Many conventional transplantation methods like autograft, iso-graft and allograft are in existence for ages, but they are not sufficient to treat all types of tissue or organ damages. Stem cells, with their unique capabilities like self-renewal and differentiate into various cell types, can be a potential strategy for tissue regeneration. However, the challenges like reproducibility, uncontrolled propagation and differentiation, isolation of specific kinds of cell and tumorigenic nature made these stem cells away from clinical application. Today, various types of stem cells like embryonic, fetal or gestational tissue, mesenchymal and induced-pluripotent stem cells are under investigation for their clinical application. Tissue engineering helps in configuring the stem cells to develop into a desired viable tissue, to use them clinically as a substitute for the conventional method. The use of stem cell-derived Extracellular Vesicles (EVs) is being studied to replace the stem cells, which decreases the immunological complications associated with the direct administration of stem cells. Tissue engineering also investigates various biomaterials to use clinically, either to replace the bones or as a scaffold to support the growth of stemcells/ tissue. Depending upon the need, there are various biomaterials like bio-ceramics, natural and synthetic biodegradable polymers to support replacement or regeneration of tissue. Like the other fields of science, tissue engineering is also incorporating the nanotechnology to develop nano-scaffolds to provide and support the growth of stem cells with an environment mimicking the Extracellular matrix (ECM) of the desired tissue. Tissue engineering is also used in the modulation of the immune system by using patient-specific Mesenchymal Stem Cells (MSCs) and by modifying the physical features of scaffolds that may provoke the immune system. This review describes the use of various stem cells, biomaterials and the impact of nanotechnology in regenerative medicine.


Author(s):  
Sven R. Hauck ◽  
Alexander Kupferthaler ◽  
Marlies Stelzmüller ◽  
Wolf Eilenberg ◽  
Marek Ehrlich ◽  
...  

Abstract Purpose To test a stent-graft specifically designed for the ascending aorta in phantom, cadaver, and clinical application, and to measure deployment accuracy to overcome limitations of existing devices. Methods A stent-graft has been designed with support wires to fixate the apices toward the inner curvature, thereby eliminating the forward movement of the proximal end which can happen with circumferential tip capture systems. The device was deployed in three aortic phantoms, and in four cadavers, deployment precision was measured. Subsequently, the device was implanted in a patient to exclude a pseudoaneurysm originating from the distal anastomosis after ascending aortic replacement. Results The stent-grafts were successfully deployed in all phantoms and cadavers. Deployment accuracy of the proximal end of the stent-graft was within 1 mm proximally and 14 mm distally to the intended landing zone on the inner curvature, and 2–8 mm distal to the intended landing zone on the outer curvature. In clinical application, the pseudoaneurysm could be successfully excluded without complications. Conclusion The novel stent-graft design promises accurate placement in the ascending aorta. The differential deployment of the apices at the inner and outer curvatures allows deployment perpendicular to the aortic axis. Level of Evidence No level of evidence.


Micromachines ◽  
2021 ◽  
Vol 12 (7) ◽  
pp. 770
Author(s):  
Chen Pan ◽  
Yafeng Han ◽  
Jiping Lu

Percutaneous Coronary Intervention (PCI) is currently the most conventional and effective method for clinically treating cardiovascular diseases such as atherosclerosis. Stent implantation, as one of the ways of PCI in the treatment of coronary artery diseases, has become a hot spot in scientific research with more and more patients suffering from cardiovascular diseases. However, vascular stent implanted into vessels of patients often causes complications such as In-Stent Restenosis (ISR). The vascular stent is one of the sophisticated medical devices, a reasonable structure of stent can effectively reduce the complications. In this paper, we introduce the evolution, performance evaluation standards, delivery and deployment, and manufacturing methods of vascular stents. Based on a large number of literature pieces, this paper focuses on designing structures of vascular stents in terms of “bridge (or link)” type, representative volume unit (RVE)/representative unit cell (RUC), and patient-specific stent. Finally, this paper gives an outlook on the future development of designing vascular stents.


Author(s):  
А. М. Осадчук ◽  
И. Л. Давыдкин ◽  
И. А. Золотовская

Развитие тромботических реакций, приводящих к нежелательным клиническим последствиям у лиц пожилого возраста, известно при многих заболеваниях, включая патологию сердечно-сосудистой системы. Сегодня идет накопление данных о степени выраженности изменений системы гемостаза у пациентов с новой коронавирусной инфекцией (COVID-19) и изучение тромбоцитарного и плазменного звена. Для понимания некоторых механизмов, связанных с патологией тромбоцитов, нами представлен обзор, в котором обобщены сведения о патофизиологических реакциях тромбоцитов в условиях их старения и возможных механизмах их патологической агрегации. Возможно, представленные фундаментальные и клинические данные будут интересны широкой аудитории специалистов для обсуждения ранней антитромбоцитарной терапии и ее обоснования не только у пациентов с сердечно-сосудистыми заболеваниями, но и с COVID-19. The development of thrombotic reactions that lead to undesirable clinical consequences in the elderly is known in many diseases, including pathology of the cardiovascular system. Today, data on the severity of changes in the hemostatic system in patients with a new coronavirus infection (COVID-19) and the study of platelet and plasma levels are being accumulated. In order to understand some of the mechanisms associated with platelet pathology, we present a review that summarizes information about the pathophysiological reactions of platelets in the conditions of their aging and possible mechanisms of their pathological aggregation. Perhaps the presented fundamental and clinical data will be of interest to a wide audience of specialists to discuss early antiplatelet therapy and its justification not only in patients with cardiovascular diseases, but also with COVID-19.


Sign in / Sign up

Export Citation Format

Share Document